[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"non-hepatobiliary-indications\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:non-hepatobiliary-indications":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100647894","eus-guided-ati-and-swe-in-individuals-with-normal-fibroscan-100647894",false,"NCT07714941","EUS-Guided ATI and SWE in Individuals With Normal FibroScan","\"EUS-Guided Attenuation Imaging and Shear Wave Elastography in Individuals With Normal FibroScan: Establishing Preliminary Reference Values in a Pilot Feasibility Study\".","EUS ATI&SWE","Inclusion Criteria:\n\n* Adults aged 18 years or older.\n* Undergoing clinically indicated diagnostic endoscopic ultrasound (EUS).\n* Same-day FibroScan examination available.\n* Controlled Attenuation Parameter (CAP) \\\u003C238 dB\u002Fm.\n* Liver Stiffness Measurement (LSM) \\\u003C7.5 kPa.\n* At least 10 valid FibroScan measurements.\n* FibroScan interquartile range (IQR)\u002Fmedian ≤30%.\n* Able and willing to provide written informed consent.\n\nExclusion Criteria:\n\n* Known chronic liver disease.\n* Hepatitis B or Hepatitis C infection.\n* Significant alcohol consumption.\n* Decompensated cirrhosis.\n* Portal vein thrombosis.\n* Ascites.\n* Focal liver lesion.\n* Previous liver surgery.\n* Pregnancy.\n* Inadequate FibroScan examination.\n* Poor-quality EUS-guided Attenuation Imaging (ATI) or Shear Wave Elastography (SWE) acquisition.\n* Incomplete study data or withdrawal of informed consent.","ALL","18 Years",{"count":20,"type":21},100,"ESTIMATED","1 Day","OBSERVATIONAL","The goal of this observational study is to establish preliminary reference values for Endoscopic Ultrasound (EUS)-guided Attenuation Imaging (ATI) and Shear Wave Elastography (SWE) in adults undergoing diagnostic EUS for non-hepatobiliary indications who have normal FibroScan findings. The main questions it aims to answer are:\n\nWhat are the preliminary normal reference values for EUS-guided ATI in the right and left hepatic lobes? What are the preliminary normal reference values for EUS-guided SWE elasticity (kPa) and velocity (m\u002Fs) in the right and left hepatic lobes?\n\nParticipants will:\n\nUndergo same-day FibroScan assessment to confirm normal liver stiffness and steatosis parameters.\n\nUndergo EUS-guided ATI and SWE measurements of both the right and left hepatic lobes during their clinically indicated diagnostic EUS examination.\n\nHave demographic, clinical, and laboratory information recorded for analysis.",[26],"Non-hepatobiliary Indications",[28,29,30,31,32,33],"Endoscopic Ultrasound (EUS)","Attenuation Imaging (ATI)","Shear Wave Elastography (SWE)","Liver Fibrosis","Controlled Attenuation Parameter (CAP)","Liver Stiffness Measurement (LSM)","NOT_YET_RECRUITING","2026-07-15",{"date":37,"type":38},"2026-07-20","ACTUAL",{"date":40,"type":21},"2026-08-20",{"date":42,"type":21},"2027-09-20",{"name":44,"class":45},"Asian Institute of Gastroenterology, India","OTHER"]